Reaction

Hepatocellular Damage reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,257 reports · 22 co-occurring drugs

As of the last recalculation, Hepatocellular Damage appears in 2,257 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 18.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rifampicin2018.418.4
Pyrazinamide1312.812.8
Olanzapine Pamoate5011.511.5
Nevirapine1010.310.3
Amlodipine Besylate And Benazepril Hydrochloride99.09.0
Lopinavir And Ritonavir138.98.9
Dalteparin Sodium108.88.8
Quinine88.68.6
Propofol338.48.4
Gemfibrozil127.37.3
Celecoxib926.76.7
Extended Phenytoin Sodium126.66.6
Abacavir Sulfate76.66.6
Raloxifene Hydrochloride106.36.3
Interferon Beta-1B125.85.8
Fondaparinux Sodium55.75.7
Rifampin95.75.7
Ritonavir165.15.1
Loratadine And Pseudoephedrine Sulfate44.64.6
Sevoflurane44.44.4
Atomoxetine Hydrochloride103.93.9
Hydrocodone Bitartrate102.12.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.